148 related articles for article (PubMed ID: 31145313)
1. A high mutation rate of immunoglobulin heavy chain variable region gene associates with a poor survival and chemotherapy response of mantle cell lymphoma patients.
Li X; Wu N; Li B
Medicine (Baltimore); 2019 May; 98(22):e15811. PubMed ID: 31145313
[TBL] [Abstract][Full Text] [Related]
2. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.
Walsh SH; Thorsélius M; Johnson A; Söderberg O; Jerkeman M; Björck E; Eriksson I; Thunberg U; Landgren O; Ehinger M; Löfvenberg E; Wallman K; Enblad G; Sander B; Porwit-MacDonald A; Dictor M; Olofsson T; Sundström C; Roos G; Rosenquist R
Blood; 2003 May; 101(10):4047-54. PubMed ID: 12637326
[TBL] [Abstract][Full Text] [Related]
3. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
Jain P; Nogueras González GM; Kanagal-Shamanna R; Rozovski U; Sarwari N; Tam C; Wierda WG; Thompson PA; Jain N; Luthra R; Quesada A; Sanchez-Petitto G; Ferrajoli A; Burger J; Kantarjian H; Cortes J; O'Brien S; Keating MJ; Estrov Z
Br J Haematol; 2018 Jan; 180(1):33-40. PubMed ID: 29164608
[TBL] [Abstract][Full Text] [Related]
4. The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
Abramenko I; Bilous N; Chumak A; Kryachok I; Fedorenko Z; Martina Z; Dyagil I
Leuk Res; 2021 Nov; 110():106686. PubMed ID: 34492598
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Visentin A; Facco M; Gurrieri C; Pagnin E; Martini V; Imbergamo S; Frezzato F; Trimarco V; Severin F; Raggi F; Scomazzon E; Pravato S; Piazza F; Semenzato G; Trentin L
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):678-685.e4. PubMed ID: 31371221
[TBL] [Abstract][Full Text] [Related]
6. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
[TBL] [Abstract][Full Text] [Related]
7. Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells.
Ghiotto F; Marcatili P; Tenca C; Calevo MG; Yan XJ; Albesiano E; Bagnara D; Colombo M; Cutrona G; Chu CC; Morabito F; Bruno S; Ferrarini M; Tramontano A; Fais F; Chiorazzi N
Mol Med; 2011; 17(11-12):1188-95. PubMed ID: 21785810
[TBL] [Abstract][Full Text] [Related]
8. Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Sandoval-Sus JD; Chavez JC; Dalia S; Naqvi SMH; Talati C; Nodzon L; Kharfan-Dabaja MA; Pinilla-Ibarz J
Leuk Lymphoma; 2018 Jan; 59(1):59-68. PubMed ID: 28641468
[TBL] [Abstract][Full Text] [Related]
9. Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma.
Panero J; Alves-Paiva RM; Roisman A; Santana-Lemos BA; Falcão RP; Oliveira G; Martins D; Stanganelli C; Slavutsky I; Calado RT
Am J Hematol; 2016 May; 91(5):481-5. PubMed ID: 26852175
[TBL] [Abstract][Full Text] [Related]
10. IGHV gene usage and mutational status in follicular lymphoma: Correlations with prognosis and patient age.
Berget E; Molven A; Løkeland T; Helgeland L; Vintermyr OK
Leuk Res; 2015 Jul; 39(7):702-8. PubMed ID: 25900812
[TBL] [Abstract][Full Text] [Related]
11. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.
Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Vegliante MC; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Calasanz MJ; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Giné E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Beà S; Campo E
Cancer Res; 2012 Oct; 72(20):5307-16. PubMed ID: 22915760
[TBL] [Abstract][Full Text] [Related]
12. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases.
Hadzidimitriou A; Agathangelidis A; Darzentas N; Murray F; Delfau-Larue MH; Pedersen LB; Lopez AN; Dagklis A; Rombout P; Beldjord K; Kolstad A; Dreyling MH; Anagnostopoulos A; Tsaftaris A; Mavragani-Tsipidou P; Rosenwald A; Ponzoni M; Groenen P; Ghia P; Sander B; Papadaki T; Campo E; Geisler C; Rosenquist R; Davi F; Pott C; Stamatopoulos K
Blood; 2011 Sep; 118(11):3088-95. PubMed ID: 21791422
[TBL] [Abstract][Full Text] [Related]
14. Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
Visco C; Moretta F; Falisi E; Facco M; Maura F; Novella E; Nichele I; Finotto S; Giaretta I; Ave E; Perbellini O; Guercini N; Scupoli MT; Trentin L; Trimarco V; Neri A; Semenzato G; Rodeghiero F; Pizzolo G; Ambrosetti A
Am J Hematol; 2013 Apr; 88(4):277-82. PubMed ID: 23450508
[TBL] [Abstract][Full Text] [Related]
15. The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia.
Gladstone DE; Blackford A; Cho E; Swinnen L; Kasamon Y; Gocke CD; Griffin CA; Bolaños-Meade J; Jones RJ
Clin Lymphoma Myeloma Leuk; 2012 Apr; 12(2):132-7. PubMed ID: 22285608
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of immunoglobulin variable heavy chain gene mutation status with prognosis in patients with mantle cell lymphoma].
Ji H; Tang Y; He Y; Jiang W; Liao D; Liu W; Li G
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):90-4. PubMed ID: 25916638
[TBL] [Abstract][Full Text] [Related]
17. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
18. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
[TBL] [Abstract][Full Text] [Related]
19. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
Liu Y; Zhu P; Hu YM
Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.
Camacho FI; Algara P; Rodríguez A; Ruíz-Ballesteros E; Mollejo M; Martínez N; Martínez-Climent JA; González M; Mateo M; Caleo A; Sánchez-Beato M; Menárguez J; García-Conde J; Solé F; Campo E; Piris MA
Blood; 2003 May; 101(10):4042-6. PubMed ID: 12511405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
